CYTOSORBENTS CORPORATION - COMMON STOCK

NetDania - New 12 months Low: CYTOSORBENTS CORPORATION - COMMON STOCK

16 Apr 2024 09:57:39 By NetDania Notify

CytoSorbents Reports Fourth Quarter and Full Year 2023 Results

14 Mar 2024 16:39:31 By Nasdaq GlobeNewswire

CytoSorbents to Report Fiscal 2023 Operating and Financial Results

06 Mar 2024 07:00:00 By Nasdaq GlobeNewswire

CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference

08 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOSORBENTS CORPORATION - COMMON STOCK

25 Jan 2024 10:26:32 By NetDania Notify

Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients

17 Jan 2024 07:15:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOSORBENTS CORPORATION - COMMON STOCK

08 Jan 2024 10:16:09 By NetDania Notify

NetDania - New 12 months Low: CYTOSORBENTS CORPORATION - COMMON STOCK

28 Dec 2023 09:48:08 By NetDania Notify

CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation

28 Dec 2023 07:00:00 By Nasdaq GlobeNewswire

CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering

13 Dec 2023 09:15:00 By Nasdaq GlobeNewswire

CytoSorbents Reports Third Quarter 2023 Financial and Operational Results

09 Nov 2023 16:15:00 By Nasdaq GlobeNewswire

CytoSorbents to Report Third Quarter 2023 Operating and Financial Results

27 Oct 2023 07:00:00 By Nasdaq GlobeNewswire

CytoSorbents to Present at the 8th Annual Dawson James Conference

05 Oct 2023 07:00:00 By Nasdaq GlobeNewswire

CytoSorbents Highlights Upcoming Presentations at EACTS 2023: Focus on Antithrombotic Removal including the 2nd Analysis of the International STAR Registry

27 Sep 2023 07:00:00 By Nasdaq GlobeNewswire

CytoSorbents Announces Kathleen P. Bloch To Resume as Full-Time Chief Financial Officer

19 Sep 2023 07:00:00 By Nasdaq GlobeNewswire

CytoSorb with Ex Vivo Organ Perfusion: Transforming the Future of Solid Organ Transplantation

11 Sep 2023 11:32:17 By Nasdaq GlobeNewswire

CytoSorbents Announces Resignation of Chief Financial Officer Alexander D’Amico

01 Sep 2023 16:43:18 By Nasdaq GlobeNewswire

CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil

31 Aug 2023 07:00:00 By Nasdaq GlobeNewswire

CytoSorbents Reports Second Quarter 2023 Financial and Operational Results

01 Aug 2023 16:15:01 By Nasdaq GlobeNewswire

CytoSorbents to Report Second Quarter 2023 Operating and Financial Results

26 Jul 2023 07:00:00 By Nasdaq GlobeNewswire